Doctor profile · Federal record
Dr. Mikel Cross
Family Nurse Practitioner (CMS: Nurse Practitioner) · Oklahoma City, OK
- NPI 1407127202
- Accepts Medicare
- 15 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3209 Nw Expressway
Oklahoma City, OK 731124131
(405) 842-3209
fax (405) 628-6898
Credentials & registration
- NPI registered
- January 2012 — 14 yrs on file
- Profile last updated
- January 28, 2022
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Oklahoma #R0086611
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1407127202. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
386
Distinct HCPCS
4
Medicare allowed
$38,635
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 181 | 128 | $101 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 96 | 96 | $130 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 93 | 82 | $69 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 16 | 16 | $89 |
In context: peer comparison
Among 116 peers in this city , average services per provider: 130. This provider delivers 3.0× the peer median.Open Payments
Industry payments received
All-time total
$1,057
Transactions
62
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 26 | $374.50 | |
| Janssen Biotech, Inc. | 5 | $74.90 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72.45 | |
| QOL Medical, LLC | 3 | $61.16 | |
| Merck Sharp & Dohme LLC | 3 | $50.07 | |
| Lilly USA, LLC | 2 | $49.17 | |
| PFIZER INC. | 2 | $47.53 | |
| Celgene Corporation | 3 | $43.78 | |
| AIMMUNE THERAPEUTICS, INC. | 2 | $40.54 | |
| Ardelyx, Inc. | 2 | $35.89 | |
| IRONWOOD PHARMACEUTICALS, INC | 2 | $35.33 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $35.27 | |
| GENZYME CORPORATION | 2 | $33.29 | |
| Gilead Sciences, Inc. | 2 | $29.96 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $27.26 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
353
Patients
133
Total drug cost
$40,894
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Omeprazole | Generic | 143 | 60 | $3,651 |
| Pantoprazole Sodium | Generic | 108 | 48 | $3,241 |
| Linzess (Linaclotide) | Brand | 36 | 14 | $21,921 |
| Famotidine | Generic | 28 | 11 | $1,168 |
| Colestipol Hcl | Generic | 24 | 0 | $2,805 |
| Trulance (Plecanatide) | Brand | 14 | 0 | $8,109 |
Hospital affiliations
Frequently asked questions
What is Dr. Mikel Cross's medical specialty?
Dr. Mikel Cross practices Family Nurse Practitioner in Oklahoma City, OK.
Where does Dr. Mikel Cross practice?
Dr. Mikel Cross practices at 3209 Nw Expressway, Oklahoma City, OK 731124131. Office phone: 4058423209.
What is Dr. Mikel Cross's NPI?
Dr. Mikel Cross's National Provider Identifier (NPI) is 1407127202, issued by NPPES.
Does Dr. Mikel Cross accept Medicare assignment?
Yes. Dr. Mikel Cross accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mikel Cross commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99204); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.